Business

In Ovations Holdings, Inc. Announces the Licensing of Technology for Early Detection of Lung Cancer

In Ovations Holdings, Inc. Announces the Licensing of Technology for Early Detection of Lung Cancer.

articleIn Ovations Holdings IncJune 10, 20143/company/in-ovations-hldgs-in/news/in-ovations-holdings-inc-announces-the-licensing-of-technology-for-early-detection-of-lung-cancer
In Ovations Holdings, Inc. Announces the Licensing of Technology for Early Detection of Lung Cancer

About this update from In Ovations Holdings Inc

[{"type":"text","content":"\n \n \n In Ovations Holdings, Inc. Announces the Licensing of Technology for Early Detection of Lung Cancer\n \n \nIn Ovations Holdings, Inc. Announces the Licensing of Technology for Early Detection of Lung Cancer\n \n DORAL, FL--(Marketwired - Jun 10, 2014) - In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) has concluded negotiations for licensing sophisticated sputum cytology technology for early and pre stage detection of lung cancer from Mel Ehrlich, Ph.D., who is also an officer and director of INOH. Dr. Ehrlich has invented, patented, perfected and marketed multiple biomedical and energy efficiency technologies.\n Pursuant to the license, INOH obtained exclusive rights to market the sputum cytology and related technologies world-wide from Dr. Ehrlich.\n Lung cancer detection is presently slow, labor-intensive, expensive and ineffective until the cancer has developed which is often too late. Dr. Ehrlich's scanning \"microspectrophotometer\" can detect cancer before it develops through analysis of the shape of pre-cancerous lung cells. It uses ultraviolet absorption of unstained cells which is cost effective, can be done in real time, and can have a higher confidence level of accuracy. This UV light beam produces a \"raster\" -- an area which is scanned from side to side in lines from top to bottom from two oscillating mirrors. Dr. Ehrlich and his team are presently increasing the accuracy and speed of the cytology scanner for commercial use.\n A comprehensive evaluation of Dr. Ehrlich's sputum cytology technology is available on the Company's website: http://inovationsholdings.com/cytometry/\n Background\n In Ovations Holdings, Inc. is pursuing several potential business opportunities. Its subsidiary, Electro Verde, Inc., markets, in conjunction with Coordinated Systems International, the patented GradiLuxtm Total Lighting System Solution which can reduce electricity consumption and carbon emissions in municipal lighting systems worldwide. The Company is also engaged in a Caribbean-based marine-related eco-tourism business and ocean search and recovery operations using state-of-the-art technology. Finally, it is a minority owner of Atmospheric Water Solutions, a company involved in water purification.\n Safe Harbor Statement:\n Under the Private Securities Litigation Reform Act of 1995: This press release ma...

More updates from In Ovations Holdings Inc